Dow Down 0.17% Nasdaq Down 0.28%

Sinovac Biotech Ltd. (SVA)

-NasdaqGS
4.81 Up 0.24(5.25%) Sep 30, 4:00PM EDT
Prev Close:4.57
Open:4.56
Bid:N/A
Ask:5.47 x 500
1y Target Est:9.50
Beta:0.21
Next Earnings Date:N/A
Day's Range:4.51 - 4.85
52wk Range:4.51 - 8.14
Volume:116,836
Avg Vol (3m):201,652
Market Cap:267.74M
P/E (ttm):48.59
EPS (ttm):0.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SVA

Comparison

Symbol% ChgMkt Cap
SVAUp 5.25%267.74M
GSKDown 0.69%110.42B
SNYUp 1.29%148.08B

Key Statistics

Forward P/E (1 yr):53.44
P/S (ttm):3.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.04
Quarterly EPS Est (Sep-14) :0.02
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-10.23

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sinovac Biotech Ltd., a biopharmaceutical company, is engaged in the research, development, manufacture, and commercialization of vaccines for hepatitis A, hepatitis B, and influenza viruses in the People's Republic of China. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback